Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Sleepose

Sleepose
In stock
10mg
from A$8.89
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$10.67A$8.89
A$0.89 per tablet

In brief

  • In our pharmacy, you can buy sleepose without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
  • Sleepose is used to help with insomnia, jet lag, delayed sleep phase and stress-related sleep problems; it contains melatonin, a naturally occurring hormone that acts on MT1/MT2 receptors in the brain to help regulate the sleep–wake cycle.
  • The usual dose is one tablet (Sleepose 20 contains 20 mg melatonin) taken as directed by a healthcare professional; note that many melatonin products use much lower doses (commonly 1–5 mg), so follow advice if dose adjustment is needed.
  • The form of administration is an orally disintegrating tablet (DT) designed to dissolve on the tongue and be swallowed without water.
  • Sleepose typically starts to work within 30–60 minutes after taking it.
  • The duration of action is usually around 4–8 hours, depending on individual factors and formulation.
  • Avoid alcohol while taking Sleepose, as alcohol can increase drowsiness, worsen sleep quality and heighten side effects.
  • The most common side effect is drowsiness; other reported effects include headache, nausea, abdominal cramps, confusion and irritability.
  • Would you like to try “sleepose” without a prescription?

Basic Sleepose Information

  • INN (International Nonproprietary Name): Not explicitly listed as it contains melatonin, a hormone.
    However, melatonin is the key active ingredient.
  • Brand Names Available In Australia: Sleepose is primarily available in India, with no widespread international brand variations noted.
  • ATC Code: N05CX02 (Melatonin) – This code is used for melatonin supplements, classified under psycholeptics (hypnotics and sedatives).
  • Forms & Dosages: Available as a disintegrating tablet (DT) containing melatonin, likely in a 20 mg dosage.
  • Manufacturers In Australia: Not specified.
  • Registration Status In Australia: Not specified.
  • OTC / Rx Classification: Over-the-counter (OTC) in the market where Sleepose is registered.

Critical Warnings & Restrictions (Patient Protection First)

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Sleepose contains melatonin reported as 20 mg per disintegrating tablet.

Pregnancy and breastfeeding are listed as absolute contraindications in the product brief.

Pregnant or lactating people must not self-medicate and should seek obstetric or GP advice.

People with autoimmune disease, severe hepatic impairment, severe renal impairment or significant psychiatric illness should consult a specialist before melatonin use.

Elderly patients are at increased risk of prolonged drowsiness, falls and confusion with melatonin.

Dose adjustments and supervised initiation are recommended for older adults.

  • High-Risk Groups For Counselling At Point Of Sale:
    elderly patients with frailty or recent falls, pregnant or breastfeeding people, people with autoimmune disease, people with severe hepatic impairment, people with severe renal impairment, people with significant psychiatric illness, people on multiple CNS depressants.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Melatonin can impair alertness and reaction times after dosing.

Advise patients not to drive, operate heavy machinery or undertake safety-critical work until they know how they respond.

Recommend avoiding these activities for at least 24 hours after dosing unless fully alert earlier.

Employers and employees should consider Work Health And Safety (WHS) obligations when staff use sedative agents.

Document counselling where workplace safety or fitness-for-duty is relevant.

  • Occupational Safety Checklist:
    patient name and role, dose and time taken, concurrent alcohol or other sedative use, planned tasks that are safety-critical, record of counselling and recommended exclusion period.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: No, not until you know how you react.

Melatonin can reduce alertness and slow reaction times for some people and that is more likely with higher doses such as 20 mg.

Clinically and legally, avoid driving or performing safety-critical work for 24 hours after taking melatonin unless you are sure you are fully alert sooner.

If you feel drowsy at any time after dosing then do not drive and postpone safety-sensitive tasks until the effect has worn off.

Signal to your GP or pharmacist if you must take melatonin and hold a role with safety-sensitive duties so workplace adjustments can be discussed.

Document any advice given about driving and workplace safety in the patient record.

Usage Basics

INN, Brand Names Available In Australia

Melatonin is the International Nonproprietary Name (INN) for the active hormone in Sleepose.

Circadin is a commonly known prescription melatonin product available in some markets as prolonged-release 2 mg tablets.

Over-the-counter melatonin supplements from brands like Blackmores, Swisse and Nature’s Own are commonly sold through retailers in Australia as supplements.

Sleepose is not widely listed in Australian pharmacy catalogues and appears primarily in Indian outlets.

Confirm TGA/ARTG registration before recommending importation or use of Sleepose in Australian practice.

  • Definitions:
    INN: melatonin;
    Brand: Sleepose (marketed from India) and other brands such as Circadin or Meloset;
    Form: disintegrating tablet (DT) for Sleepose and prolonged-release (ER) for Circadin;
    ATC Code: N05CX02.

Legal Classification (TGA-Approved, PBS-Listed)

In Australia melatonin is generally prescription-only (S4) depending on formulation and indication.

Circadin (melatonin 2 mg ER) is a prescription product in many jurisdictions and PBS access is limited and conditional.

Over-the-counter availability in other countries does not guarantee legal supply in Australia.

  • How To Verify TGA Approval:
    check the Australian Register Of Therapeutic Goods (ARTG) online, confirm product name and sponsor, and verify formulation and dosage listed.
  • Imported Product Oversight:
    confirm whether an imported melatonin product requires a Special Access Scheme (SAS), Authorised Prescriber approval or can be brought in under personal importation rules.
  • Advise patients to consult their GP or pharmacist before ordering unregistered products and to check PBS criteria for subsidy.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Reported Sleepose strength is 20 mg melatonin per disintegrating tablet.

This is higher than many Australian prescription products such as Circadin 2 mg prolonged-release tablets.

Standard clinical starting doses in adults often range from 0.5 mg to 5 mg for sleep onset problems.

Higher doses may be used under specialist supervision but increase the risk of adverse effects.

Older adults and people with comorbidities should start at the lowest effective dose.

Product Strength Typical Indication
Sleepose 20 Tablet DT Melatonin 20 mg Insomnia, stress-related sleep disturbance (as marketed)
Circadin 2 mg ER Melatonin 2 mg (prolonged-release) Primary insomnia, often in older adults (prescription)
Meloset 3 mg Melatonin 3 mg Sleep onset issues (supplement formulations)

Adjustments For Comorbidities

Dose adjustments should be made for hepatic impairment, polypharmacy and frail elderly patients.

Children are not covered by Sleepose product notes and paediatric use requires specialist prescription and guidance.

When in doubt consult a sleep specialist or treating physician.

  • Dose Review Checklist:
    patient age, liver and kidney function, current interacting medicines, concomitant CNS depressants, history of psychiatric or autoimmune disease, fall risk assessment.

Q&A — “What If I Miss A Dose?”

If you miss a bedtime dose, take the next dose at your usual time and do not double dose to catch up.

Do not take extra tablets during the day to make up a missed night dose.

If you are taking melatonin for jet lag, follow the timing guidance for your destination rather than doubling doses.

If an accidental extra dose has been taken and symptoms such as severe drowsiness, confusion or persistent vomiting occur then seek medical attention.

Contact your GP or pharmacist if you are unsure about timing after a missed dose or after accidental overdose.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Alcohol can potentiate melatonin’s sedative effects and increase next-day drowsiness.

Caffeine and energy drinks may counteract the sedative onset but do not reliably alter melatonin metabolism.

In Australia common habits such as late caffeinated beverages or alcohol at social events are relevant when counselling on timing of dose.

  • Increase Sedation:
    alcohol, energy drinks combined with benzodiazepines or opioids, heavy meals with alcohol.
  • Reduce Effect:
    late caffeine consumption, stimulants such as decongestants or some ADHD medicines may blunt subjective sleepiness.

Common Drug Conflicts

Melatonin interacts with several drug classes and with enzymes such as CYP1A2 and CYP2C19.

Warfarin interaction has been reported and INR should be monitored when melatonin is started or stopped.

Benzodiazepines, opioids and antipsychotics can have additive sedative effects with melatonin.

High-Risk Drug Class Suggested Action
Benzodiazepines and Z‑drugs Monitor for additive sedation; consider dose reduction or alternative therapy.
Opioids Avoid co‑administration where possible; monitor closely for respiratory depression and sedation.
Anticoagulants (eg warfarin) Monitor INR when initiating or stopping melatonin; liaise with GP.
CYP1A2/CYP2C19 Modulators Consider interaction potential; adjust dose or monitor for increased effects.
Antidepressants Review risk of serotoninergic effects and sedation; consult prescriber.

User Reports & Trends

Australian user feedback for melatonin products varies across forums and review sites.

Many users report improved sleep onset but mixed results for sustained sleep and daytime functioning.

Low-dose melatonin (2–3 mg) commonly receives positive comments on sleep latency improvements.

High-dose OTC products attract concern about residual drowsiness and safety.

Sleepose 20 mg appears primarily sold via Indian outlets and is less discussed in Australia.

Importation concerns include label accuracy, excipients and product authenticity.

  • Common Patient Themes:
    sleep onset benefit, residual drowsiness, headache, price sensitivity, sourcing and authenticity issues.
Sentiment Typical Complaints
Positive Faster sleep onset, easier bedtime routine
Neutral Variable effect, benefits only for certain sleep problems
Negative Next-day drowsiness, headache, concern about high doses or imported products

Ask patients about imported product use during medication history and document brands and doses taken.

Access & Purchase Options

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Major pharmacy chains in Australia sell melatonin products and supplements through in-store and online channels.

Prescription melatonin such as Circadin is dispensed via community pharmacies when a valid prescription is supplied.

Imported products like Sleepose may not be stocked by major chains and patients sometimes attempt online importation.

  • Pharmacist Triage Checklist:
    confirm ARTG or registration status, check product label and active ingredient, advise on legal status and import risk, recommend local alternatives and document counselling and agreed actions.

In our online pharmacy, sleepose is available without a prescription, with discreet delivery to Australia in 9-21 days.

Online Pharmacies And Telehealth E-Prescriptions

Telehealth can be used to obtain a prescription for melatonin where clinically indicated and e-prescriptions facilitate rural access.

Warn about unregulated international sellers and prefer registered Australian pharmacies or legal importation pathways.

Route Availability Legal Risk Cost / Counselling
In‑Store Pharmacy Common for supplements and prescription dispense Low when product ARTG registered Moderate cost, face-to-face counselling available
Online Australian Pharmacy Good for supplements and prescriptions Low when from registered supplier Variable cost, pharmacist counselling by phone or chat
Import From Overseas Possible but unpredictable Higher legal and authenticity risk Often lower cost but limited local counselling

Mechanism & Pharmacology

Simplified Explanation

  • Melatonin: An endogenous hormone produced by the pineal gland that signals night-time to the body.
  • Chronobiotic: A compound that can shift circadian rhythms and help realign sleep timing, useful for jet lag or delayed sleep phase.
  • Hypnotic Effect: Exogenous melatonin can promote sleep onset in susceptible individuals.
  • Half-Life: Melatonin is rapidly absorbed with a short half-life; formulation and dose influence duration of effect.

Immediate-release formulations promote sleep onset while prolonged-release can help maintain sleep.

High doses, such as 20 mg, can produce longer systemic exposure and a higher risk of adverse effects.

Clinical Terms

Pharmacokinetics: melatonin is rapidly absorbed and undergoes first-pass metabolism in the liver.

Interactions with CYP enzymes such as CYP1A2 and CYP2C19 can affect melatonin levels and duration of action.

Pharmacodynamics: there is substantial interindividual variability in response and elderly patients often show altered pharmacodynamics.

  • Clinical Implications:
    start low and titrate, monitor for daytime drowsiness, consider dose adjustment with CYP modulators and assess fall risk in older adults.

Indications & Off-Label Uses

Approved Indications By TGA

Check the TGA/ARTG for current Australian approvals for melatonin products such as Circadin.

Sleepose product literature lists insomnia, stress-related sleep disturbances and jet lag as intended uses.

In Australian practice melatonin is prescribed for circadian rhythm sleep disorders and selected insomnia cases.

Paediatric melatonin should only be used under specialist guidance for neurodevelopmental disorders or complex sleep disorders.

  • Indications And Referral Points:
    circadian rhythm disorders, selected insomnia after sleep hygiene and CBT-I review, jet lag management, paediatric cases requiring specialist input.

Off-Label Uses In Australian Clinical Practice

Off-label uses can include delayed sleep phase disorder, shift work disorder and adjunct use in some neurodevelopmental conditions.

Off-label prescribing should be documented with informed consent and a monitoring plan.

  • Off-Label Prescribing Checklist:
    diagnosis and formulation, clinical rationale, documented informed consent, baseline assessment, agreed review date and outcome measures.

Key Clinical Findings (Major Australian & International Studies 2022–2026)

Recent trials and meta-analyses show benefit in reducing sleep latency and some benefits in circadian disorders with modest effect sizes.

Low-dose regimens from 0.5 mg to 5 mg often provide clinically meaningful reductions in time-to-sleep onset.

Prolonged-release 2 mg formulations show improvements in total sleep time in some older adult populations.

There is limited robust trial data supporting routine use of high doses such as 20 mg and these doses may increase adverse events.

Australian research stresses careful patient selection and monitoring when prescribing melatonin.

Study Type Population Dose Range Main Outcome Safety Signals
Meta‑analysis Adults with insomnia 0.5–5 mg Reduced sleep latency Minimal short-term adverse effects
Randomised Trial Older adults 2 mg ER Improved total sleep time Some next-day drowsiness reported
Observational Reports Users of high-dose supplements ≥10 mg Variable benefit Increased reports of residual drowsiness and headache

Ongoing RCTs and updated TGA guidance will clarify optimal dosing and regulatory status.

Alternatives Matrix

PBS-Listed Alternatives Comparison Table

Product Typical Dose PBS Status Key Pros Key Cons
Circadin 2 mg ER 2 mg nightly Prescription; limited PBS subsidy (conditional) Prolonged-release, evidence in older adults Requires prescription; subsidy limited
Benzodiazepine/Z‑drug (short‑term) Agent-dependent Prescription; some PBS listings Rapid onset, effective short-term Dependency risk, cognitive adverse effects
CBT‑I N/A Not a PBS drug but covered in some services Durable benefits without drug risks Access, cost and wait times can be barriers

Pros And Cons Checklist

  • Treatment Choice Guide:
    assess severity of insomnia, comorbidities, risk of dependency, daytime impairment, regulatory status and access/cost, and patient preference.
  • Sleepose Specifics:
    pros — high dose available in source market and marketed for sleep issues;
    cons — unregulated in Australia, higher-than-usual dose vs common clinical practice, safety and importation concerns.

Common Questions (From Australian Pharmacy Consultations)

Customers frequently ask practical questions about safety, long-term use and mixing with other medicines.

  • Is It Safe Long-Term? — Evidence for long-term efficacy is limited and review is recommended regularly.
  • Is This Safe For My Child? — Not without specialist advice; paediatric use requires specialist prescription.
  • Can I Mix With Antidepressants? — Review needed due to interaction risk; consult GP or psychiatrist.
  • Will It Make Me Groggy Tomorrow? — Some patients report next-day drowsiness, especially with higher doses.
  • How Fast Does It Work? — Immediate-release formulations can act within 30–60 minutes for some people.
  • Can I Use It For Jet Lag? — Yes; timing matters and follow destination-timed dosing advice.
  • Do I Need A Prescription? — Many melatonin products are prescription-only in Australia; check ARTG and PBS rules.
  • How Should I Store It? — Keep in a cool, dry place away from children and heat.
  • What If I Feel Worse? — Stop taking and seek medical advice for significant adverse effects.
  • How Often Should I Review? — Document and review outcomes within 2–4 weeks of initiation.

Micro FAQ — “How Long Can I Try It?”

Try the lowest effective dose for a short trial period such as two to four weeks and record sleep outcomes.

If benefits are limited or side effects occur, stop and review with the GP.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Product Example Price Range (AUD) PBS Subsidy Status Prescription Required Notes
Chemist Warehouse Melatonin supplements / Circadin (prescription) From low-cost supplements to higher for prescriptions Prescription products may have limited PBS subsidy Supplements: no; Circadin: yes Authentic Australian stock when supplied locally
Priceline Melatonin supplements Low to moderate Supplements not PBS Supplements: no Pharmacist counselling available in store
TerryWhite Chemmart Prescription melatonin dispensed Prescription pricing applies Possible conditional PBS subsidy Yes for Circadin Local dispensing with pharmacist advice
Online Australian Pharmacies Supplements and prescription fulfilment Variable Prescription items may be subsidised if eligible Depends on product Prefer registered Australian suppliers
Imported Sources (eg Indian E‑pharmacies) Sleepose 20 mg Often lower but variable Not PBS Often no local prescription required at source Higher risk of authenticity and regulatory issues

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Confirm ARTG registration for the exact product and formulation.
  • Check local stock at major chains and availability online.
  • Use telehealth and e-prescriptions to obtain a legitimate prescription when required.
  • Consider courier reliability and discreet packaging for rural deliveries.
  • Recommend locally stocked alternatives when importation is risky or the patient prefers regulated products.

Registration & Regulation

TGA Approval

Product brief shows Sleepose registered in India and no ANMDMR/TGA links were provided in the source material.

Australian clinicians and pharmacists should check the TGA Australian Register Of Therapeutic Goods (ARTG) for current registration before advising use or dispensing.

Unregistered imported medicines may require Authorised Prescriber status, Special Access Scheme approval or personal importation compliance with customs and therapeutic goods laws.

PBS Subsidy Details

PBS subsidy for melatonin is limited and typically conditional.

Check current PBS schedules and authority requirements before assuming subsidy availability.

  • Regulatory Steps Checklist:
    ARTG check, consider SAS or Authorised Prescriber routes, confirm PBS authority and document eligibility when prescribing or importing melatonin.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Store Sleepose in a cool, dry place away from direct sunlight and out of children’s reach.

In hot and humid Australian climates advise patients to keep tablets below 25°C and avoid bathroom storage.

  • Household Storage Checklist:
    keep in original packaging, use child-resistant containers, check expiry dates, keep in blister until use and avoid heat sources.

Cold-Chain Handling For Pharmacies

Melatonin products generally do not require cold-chain storage.

Pharmacy storage standards should prevent heat and humidity degradation with regular stock rotation and temperature monitoring.

Setting Recommendation
Home Store below 25°C, dry place, original packaging, out of children’s reach
Pharmacy Standard shelf storage away from heat and humidity, temperature logs where appropriate
Transport Check packaging integrity on receipt and avoid prolonged exposure to heat during transit

Guidelines For Proper Use

Australian Pharmacist Counselling Style

Use a structured counselling approach when a patient requests melatonin or when reviewing imported products.

Confirm the indication and desired outcome for sleep improvement.

Discuss dose and formulation and check pregnancy and breastfeeding status specifically.

Review current medications, especially CNS depressants and anticoagulants.

Advise on driving and workplace safety and document consent and plan for review.

  • Pharmacist Counselling Checklist:
    assessment, advice on dosing and timing, actions for interactions, documented follow-up within 2–4 weeks.

Patient Advice From PBS And National Health Authorities

Follow PBS and national guidance: use the lowest effective dose and avoid alcohol and other CNS depressants while taking melatonin.

Report adverse effects and return unused medicines to a pharmacy for safe disposal.

  • Ongoing Monitoring Checklist:
    keep a sleep diary, note adverse events, medication review every 2–3 months and reassess need for continuation.

Delivery Across Australia

City Region Delivery time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 14-21 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Geelong Victoria 9-14 days
Cairns Queensland 14-21 days
Townsville Queensland 14-21 days
Ballarat Victoria 14-21 days

Related products